Evidence map›Paper›PMID 35117422›Full record

ArticleTranslational cancer research2020

High-mobility group A1 (

Maruthi Prasad E, Ting Liu, Xiang Zhang, Hongli Yang, Jing Wang, Renpeng Huang, Yuhong Wang

Erratum issuedOpen access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Maruthi Prasad E *Department of Pathology, The First Affiliated Hospital of Soochow University, Suzhou 215000, China.
Ting Liu *Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Suzhou 215000, China.
Xiang ZhangDepartment of Gynecologic Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China.
Hongli YangDepartment of Pathology, The First Affiliated Hospital of Soochow University, Suzhou 215000, China.
Jing WangJiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou 215123, China.
Renpeng HuangDepartment of Pathology, The First Affiliated Hospital of Soochow University, Suzhou 215000, China.
Yuhong WangDepartment of Pathology, The First Affiliated Hospital of Soochow University, Suzhou 215000, China.
First Affiliated Hospital of Soochow University · CNSoochow University · CNZhejiang Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe high-mobility group A1 gene (HMGA1) plays a major role in the development of malignant cancers. However, the mechanisms underlying the correlation between HMGA1 expression level and patients' overall survival rate in various malignant cancers is unclear.

methodsWe used The Cancer Genome Atlas (TCGA) database (https://genome-cancer.ucsc.edu/) to search for mRNA expression levels of

resultsHigh expression group correlated with worse survival prognosis statistically significant (P<0.05), and scatter plots showed

conclusions

Indexed as

cancerHMGA1prognosisreceiver operating characteristic (ROC)The Cancer Genome Atlas (TCGA)

Identifiers

PMID35117422
PMCPMC8798761
OpenAlexW2998752210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.